oral tyrosine kinase inhibitor

oral tyrosine kinase inhibitor
Trade Name
Orphan Indication Chronic myeloid leukemia
USA Market Approval USA
USA Designation Date 2017-06-28 00:00:00
Sponsor Fusion Pharma, LLC;Territory of the Skolkovo innovation center, Nobelya St. 7;
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia University of California, San Francisco – Chronic Myeloid Leukemia Emory University – Chronic Myeloid Leukemia Pusan National University Hospital – Chronic myeloid leukemia University of California, San Francisco – Chronic myeloid leukemia Pfizer – Chronic myeloid leukemia Emory University – Chronic myeloid leukemia